1. Home
  2. PGEN vs ROG Comparison

PGEN vs ROG Comparison

Compare PGEN & ROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.55

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Rogers Corporation

ROG

Rogers Corporation

HOLD

Current Price

$165.95

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
ROG
Founded
1998
1832
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
PGEN
ROG
Price
$5.55
$165.95
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$8.33
$133.00
AVG Volume (30 Days)
5.5M
301.2K
Earning Date
05-13-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.25
Revenue
$230,981,000.00
$879,091,000.00
Revenue This Year
$1,115.92
$7.64
Revenue Next Year
$81.04
$6.09
P/E Ratio
N/A
$648.56
Revenue Growth
N/A
7.07
52 Week Low
$1.40
$61.17
52 Week High
$5.61
$169.00

Technical Indicators

Market Signals
Indicator
PGEN
ROG
Relative Strength Index (RSI) 74.63 63.88
Support Level $4.00 $98.08
Resistance Level N/A N/A
Average True Range (ATR) 0.32 7.14
MACD 0.15 1.04
Stochastic Oscillator 96.70 85.45

Price Performance

Historical Comparison
PGEN
ROG

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

Share on Social Networks: